Home › Castration-Resistant Prostatic Cancer › New York › New York City
Castration-Resistant Prostatic Cancer clinical trials in New York City, NY
7 studies for Castration-Resistant Prostatic Cancer are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
RecruitingPhase 3
- NYU Langone Health Laura and Isaac Perlmutter Cancer Center, New York
- Columbia University Medical Center, New York
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
RecruitingPhase 3
- NYU Langone Health Laura and Isaac Perlmutter Cancer Center, New York
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
RecruitingPhase 1/2
- Memorial Sloan Kettering Cancer Center ( Site 0006), New York
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
RecruitingPhase 1
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medicine, New York
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
RecruitingPhase 1
- Memorial Sloan Kettering Cancer Center, New York
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)
RecruitingPhase 1/2
- Weill Cornell Medicine at New York-Presbyterian, New York
Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer
RecruitingPhase 1
- Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York
Castration-Resistant Prostatic Cancer trials in other cities
- Los Angeles, CA8 studies
- Seattle, WA6 studies
- Houston, TX6 studies
- Boston, MA5 studies
- Queens, NY4 studies
- Philadelphia, PA4 studies
- Pittsburgh, PA4 studies
- Mountain View, CA3 studies
- Cincinnati, OH3 studies
- San Francisco, CA3 studies
- Metairie, LA3 studies
- Baltimore, MD3 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.